These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

353 related articles for article (PubMed ID: 33867274)

  • 1. Guideline for the use of immunobiologicals in chronic rhinosinusitis with nasal polyps (CRSwNP) in Brazil.
    Anselmo-Lima WT; Tamashiro E; Romano FR; Miyake MM; Roithmann R; Kosugi EM; Nakanishi M; Fornazieri MA; Bezerra TFP; Mello JF; Lessa MM; Voegels RL; Piltcher OB; Sakano E; Valera FCP
    Braz J Otorhinolaryngol; 2022; 88(3):471-480. PubMed ID: 33867274
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Brazilian guideline for the use of immunobiologicals in chronic rhinosinusitis with nasal polyps ‒ 2024 update.
    Anselmo-Lima WT; Romano FR; Tamashiro E; Roithmann R; Dinarte VRP; Piltcher OB; Miyake MM; Fornazieri MA; Nakanishi M; Bezerra TFP; Dolci RLL; Mello JF; Lessa MM; Voegels RL; Kosugi EM; Sakano E; Valera FCP
    Braz J Otorhinolaryngol; 2024; 90(3):101394. PubMed ID: 38367543
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Role of Biologics in Chronic Rhinosinusitis With Nasal Polyposis: State of the Art Review.
    Kim C; Han J; Wu T; Bachert C; Fokkens W; Hellings P; Hopkins C; Lee S; Mullol J; Lee JT
    Otolaryngol Head Neck Surg; 2021 Jan; 164(1):57-66. PubMed ID: 32746710
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The Role of Biologics in Chronic Rhinosinusitis With Nasal Polyps.
    Patel GB; Peters AT
    Ear Nose Throat J; 2021 Jan; 100(1):44-47. PubMed ID: 33035132
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Decision-making in the treatment of chronic rhinosinusitis with nasal polyps in the era of biologics].
    Hoffmann AS; Betz CS; Böscke R; Weber RK
    HNO; 2024 Apr; 72(4):225-230. PubMed ID: 38376799
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Current and emerging biological therapies for Chronic rhinosinusitis with nasal polyps with type 2 inflammation.
    Jin Z; Yan B; Zhang L; Wang C
    Expert Opin Investig Drugs; 2023; 32(10):909-919. PubMed ID: 37855222
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The argument against the use of dupilumab in patients with limited polyp burden in chronic rhinosinusitis with nasal polyposis (CRSwNP).
    Hardison SA; Senior BA
    J Otolaryngol Head Neck Surg; 2023 Sep; 52(1):64. PubMed ID: 37759322
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Is generative pre-trained transformer artificial intelligence (Chat-GPT) a reliable tool for guidelines synthesis? A preliminary evaluation for biologic CRSwNP therapy.
    Maniaci A; Saibene AM; Calvo-Henriquez C; Vaira L; Radulesco T; Michel J; Chiesa-Estomba C; Sowerby L; Lobo Duro D; Mayo-Yanez M; Maza-Solano J; Lechien JR; La Mantia I; Cocuzza S
    Eur Arch Otorhinolaryngol; 2024 Apr; 281(4):2167-2173. PubMed ID: 38329526
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The Role of Biologics in the Treatment of Chronic Rhinosinusitis.
    Haloob N; Karamali K; Hopkins C
    BioDrugs; 2023 Jul; 37(4):477-487. PubMed ID: 37318659
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Otitis media in severe asthma associated with chronic rhinosinusitis with nasal polyps: a new therapeutic target for biologics.
    Bartier S; Béquignon E; Thibaut de Ménonville C; Verillaud B; Evrard D; Léger M; Papon JF; Coste A; Taillé C
    J Asthma; 2023 Jan; 60(1):139-144. PubMed ID: 35073225
    [No Abstract]   [Full Text] [Related]  

  • 11. Practical recommendations for managing severe chronic rhinosinusitis with nasal polyps in the era of biologics.
    De Corso E; Pipolo C; Cantone E; Ottaviano G; Gallo S; Trimarchi M; Torretta S; Cavaliere C; Lucidi D; Seccia V; Settimi S; Canevari FRM; Pasquini E; La Mantia I; Garzaro M; Bellocchi G; De Benedetto M; Lombardo N; Macchi A; Malvezzi L; Motta G; Vicini C; Maselli A; Dell'Era V; Dragonetti A; Asprea F; Lupato V; Ghidini A; Masieri S; Mattavelli D; Salzano FA; Passali D; Galli J; Pagella F
    Acta Otorhinolaryngol Ital; 2023 Oct; 43(5):324-340. PubMed ID: 37224173
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cost Utility Analysis of Dupilumab Versus Endoscopic Sinus Surgery for Chronic Rhinosinusitis With Nasal Polyps.
    Scangas GA; Wu AW; Ting JY; Metson R; Walgama E; Shrime MG; Higgins TS
    Laryngoscope; 2021 Jan; 131(1):E26-E33. PubMed ID: 32243622
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Biologics versus functional endoscopic sinus surgery for the treatment of chronic rhinosinusitis with nasal polyps: a literature review.
    Alshatti A; Webb C
    J Laryngol Otol; 2024 Apr; 138(4):361-366. PubMed ID: 37993118
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Chinese Expert Consensus on the Use of Biologics in Patients with Chronic Rhinosinusitis (2022, Zhuhai).
    Hong HY; Chen TY; Yang QT; Sun YQ; Chen FH; Lou HF; Wang HT; Yu RL; An YF; Liu F; Wang TS; Lu MP; Qiu QH; Wang XD; Chen JJ; Meng CD; Xie ZH; Meng J; Zeng M; Xu CL; Wang Y; Yang YC; Zhang WT; Tang J; Yang YL; Xu R; Yu GD; Shi ZH; Wei X; Ye HP; Sun YN; Yu SQ; Zhang TH; Yong J; Hang W; Xu YT; Xu Y; Tan GL; Sun N; Yang G; Li YJ; Ye J; Zuo KJ; Zhang LQ; Wang XY; Yang AN; Xu YX; Liao W; Fan YP; Li HB
    ORL J Otorhinolaryngol Relat Spec; 2023; 85(3):128-140. PubMed ID: 37019094
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [The perspectives of biologics in the treatment of chronic rhinosinusitis with nasal polyps].
    Zhang L
    Lin Chuang Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2023 Nov; 37(11):853-855. PubMed ID: 37905479
    [No Abstract]   [Full Text] [Related]  

  • 16. Therapeutic Strategies of Biologics in Chronic Rhinosinusitis: Current Options and Future Targets.
    Tai J; Han M; Kim TH
    Int J Mol Sci; 2022 May; 23(10):. PubMed ID: 35628333
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Chronic rhinosinusitis with nasal polyps : is there a place for monoclonal antibodies in 2020 ?].
    Clottu A; Reinhard A; Comte D
    Rev Med Suisse; 2021 Jan; 17(720-1):13-17. PubMed ID: 33443824
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pathogenesis-based application of biologics for chronic rhinosinusitis: Current and future perspectives.
    Okano M; Kanai K; Oka A
    Auris Nasus Larynx; 2024 Apr; 51(2):371-378. PubMed ID: 37743131
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Study protocol: the biologics in severe chronic rhinosinusitis with nasal polyps survey.
    Favier V; Daveau C; Carsuzaa F; Fieux M; Vandersteen C; Castillo L; Papon JF; de Gabory L; Saroul N; Verillaud B; Rumeau C; Jankowski R; Michel J; de Bonnecaze G; Lecanu JB; Coste A; Béquignon E; Malard O; Mortuaire G
    BMJ Open; 2024 May; 14(5):e083112. PubMed ID: 38749694
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Adverse effects of dupilumab in chronic rhinosinusitis with nasal polyps. Case report and narrative review.
    Nitro L; Bulfamante AM; Rosso C; Saibene AM; Arnone F; Felisati G; Pipolo C
    Acta Otorhinolaryngol Ital; 2022 Jun; 42(3):199-204. PubMed ID: 35880360
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.